Nuvasive 

$39.75
3
-$0.91-2.24% Thursday 20:00

Statistik

Tertinggi hari ini
-
Terendah hari ini
-
Tertinggi 52M
-
Terendah 52M
-
Volume
-
Vol. rata2
-
Kap. pasar
2.07B
Rasio P/E
-107.61
Imbal hasil dividen
-
Dividen
-

Laporan keuangan

7NovDiperkirakan
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
0.39
0.45
0.5
0.56
EPS yang diharapkan
0.5384
EPS aktual
N/A

Keuangan

3.36%Margin laba
Menguntungkan
2017
2018
2019
2020
2021
2022
1.2BPendapatan
40.41MLaba bersih

Orang juga mengikuti

Daftar ini didasarkan pada daftar pantauan pengguna Stock Events yang mengikuti NUVA. Ini bukan rekomendasi investasi.

Pesaing

Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.

Tentang

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Show more...
CEO
J. Christopher Barry
Karyawan
2900
Negara
US
ISIN
US6707041058
WKN
000A0CAYR

Pencatatan

0 Comments

Bagikan pendapatmu

FAQ

Berapa harga saham Nuvasive hari ini?
Harga saat ini dari NUVA adalah $39.75 USD — turun sebesar -2.24% dalam 24 jam terakhir. Pantau kinerja harga saham Nuvasive lebih dekat di grafik.
Apa simbol saham Nuvasive?
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Nuvasive diperdagangkan dengan simbol NUVA.
Berapa kapitalisasi pasar Nuvasive?
Hari ini Nuvasive memiliki kapitalisasi pasar sebesar 2.07B
Berapa pendapatan Nuvasive tahun lalu?
Pendapatan Nuvasive tahun lalu berjumlah 1.2B USD.
Berapa pendapatan bersih Nuvasive tahun lalu?
Pendapatan bersih NUVA untuk tahun lalu adalah 40.41M USD.
Berapa jumlah karyawan Nuvasive?
Per April 10, 2026, perusahaan memiliki 2,900 karyawan.
Nuvasive berada di sektor apa?
Nuvasive beroperasi di sektor Manufacturing.
Kapan Nuvasive menyelesaikan split saham?
Nuvasive belum melakukan split saham baru-baru ini.
Di mana kantor pusat Nuvasive?
Kantor pusat Nuvasive berlokasi di San Diego, US.